Company Filing History:
Years Active: 2009-2010
Title: The Innovations of Andrew J Dorner
Introduction
Andrew J Dorner is a notable inventor based in Lexington, MA (US). He has made significant contributions to the field of medical technology, particularly in the monitoring and diagnosis of diseases. With a total of 2 patents, his work has the potential to impact patient care and treatment outcomes.
Latest Patents
Dorner's latest patents include innovative methods for monitoring drug activities in vivo. The first patent focuses on methods, systems, and equipment useful for monitoring in vivo activities of CCI-779 or other drugs. This invention identifies numerous drug activity genes that can be modulated by CCI-779, making them useful as surrogate markers for detecting or monitoring drug activities in vivo. The second patent addresses methods for diagnosing renal cell carcinoma (RCC) and other solid tumors. This invention identifies disease genes that are differentially expressed in the peripheral blood of patients with RCC compared to disease-free individuals, providing a means to detect the presence or absence of these tumors.
Career Highlights
Andrew J Dorner is currently associated with Wyeth, a company known for its commitment to pharmaceutical innovation. His work at Wyeth has allowed him to focus on developing technologies that enhance drug monitoring and cancer diagnosis.
Collaborations
Dorner has collaborated with notable colleagues, including Natalie C Twine and Michael E Burczynski. These collaborations have contributed to the advancement of his research and the development of his patents.
Conclusion
Andrew J Dorner's contributions to medical technology through his patents demonstrate his commitment to improving healthcare outcomes. His innovative approaches to drug monitoring and cancer diagnosis highlight the importance of research and development in the medical field.